Cellegy Pharmaceuticals To Report On Results Of FDA’s Cardio-Renal Advisory Committee Meeting Held on April 25, 2006

HUNTINGDON VALLEY, Penn., April 26 /PRNewswire-FirstCall/ -- Cellegy Pharmaceuticals, Inc. will be hosting a conference call beginning at 12:00 p.m. Eastern Daylight Time (9:00 a.m. Pacific Daylight Time) today, Wednesday, April 26, 2006. Richard C. Williams, Chairman and Interim Chief Executive Officer, and Robert J. Caso, Vice President, Finance and Chief Financial Officer will provide an update.

To participate in the live call by telephone, please dial (866) 277-1184 from the United States, or for international callers, please dial (617) 597-5360, entering the Passcode, 32658518.

A replay will be available on Cellegy’s website for one week. A telephone replay will be available for one week by dialing (888) 286-8010 from the United States, or (617) 801-6888 for international callers, and entering Passcode 21593620.

Cellegy Pharmaceuticals, Inc. is a specialty biopharmaceutical company that develops and commercializes prescription drugs for the treatment of women’s health care conditions, including HIV prevention and sexual dysfunction, and gastrointestinal disorders.

Cellegy Pharmaceuticals, Inc.

CONTACT: Richard C. Williams, Chairman and Interim CEO, +1-650-616-2200,or Robert J. Caso, Vice President, Finance & CFO, +1-215-914-0900, ext.603, both of Cellegy Pharmaceuticals

MORE ON THIS TOPIC